Abstract: The present invention provides polypeptides, peptide dimer, and multimeric complexes comprising at least one binding moiety for KDR or VEGF/KDR complex, which have a variety of uses wherever treating, detecting, isolating or localizing angiogenesis is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding KDR or VEGF/KDR complex with high affinity (e.g., having a KD<1 ?M), and dimer and multimeric constructs comprising these polypeptides.

Abstract: The invention provides compositions and methods for therapeutic and diagnostic applications.

Abstract: A ropelight having an outer jacket; an inner core; and at least two circuits in the inner core, the at least two circuits having a plurality of bulbs electrically coupled thereto; a controller for controlling at least one of the at least two circuits; a power cable; a connector for electrically coupling the controller to the power cable, the connector being coupled to the controller; and a housing protecting the controller and the connector; and wherein the bulbs of at least one circuit are constantly on; and the bulbs of at least one circuit are flashed or dimmed at a predetermined interval.

Abstract: The invention provides compositions and methods for therapeutic and diagnostic applications.

Abstract: The invention provides compositions and methods for therapeutic and diagnostic applications.

Abstract: EXT2 polypeptides and DNA (RNA) encoding such enzyme and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such EXT2 in the development of treatments for to hereditary multiple exotoses and cancers, such as chondrosarcoma, among others, are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides.